Caricamento...
Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective
[Image: see text] Design of small-molecule inhibitors (MDM2 inhibitors) to block the MDM2–p53 protein–protein interaction has been pursued as a new cancer therapeutic strategy. In recent years, potent, selective, and efficacious MDM2 inhibitors have been successfully obtained and seven such compound...
Salvato in:
| Pubblicato in: | J Med Chem |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Chemical
Society
2014
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4329994/ https://ncbi.nlm.nih.gov/pubmed/25396320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm501092z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|